Danielle Bersabe, MD
Internal Medicine · Biloxi, MSNPI 1003177593
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.0% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $600 and has fallen 92.2% since, to $47 in 2025.
Across 79 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$222
- AbbVie$169
- Novartis$153
- EMD Serono, Inc.$124
- Regeneron Healthcare Solutions, Inc.$122
- Pfizer$113
- plus $515 from 16 others
What the payments were for
- Food & beverage$1,40499%
- Education$141%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 16 | $222 |
| AbbVie | 11 | $169 |
| Novartis | 9 | $153 |
| EMD Serono, Inc. | 1 | $124 |
| Regeneron Healthcare Solutions, Inc. | 1 | $122 |
| Pfizer | 8 | $113 |
| Novo Nordisk | 7 | $109 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $77 |
| GSK | 3 | $46 |
| Johnson & Johnson | 3 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $27 |
| Abbott | 2 | $24 |
| Acera Surgical, Inc. | 1 | $20 |
| Sunovion Pharmaceuticals Inc. | 2 | $19 |
| Boehringer Ingelheim | 1 | $18 |
| AstraZeneca | 1 | $15 |
| G1 Therapeutics, Inc. | 1 | $15 |
| Medtronic | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
| Radius Health, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,418 in reported general payments places this provider in the 70th percentile of 846 internal medicine providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dicyclomine Hcl | 15 | $237 |
| Levothyroxine Sodium | 29 | $217 |
| Atorvastatin Calcium | 27 | $141 |
| Pantoprazole Sodium | 14 | $137 |
| Carbidopa-LevodopaCarbidopa/Levodopa | 12 | $130 |
| Metformin Hcl | 11 | $44 |
| Amlodipine Besylate | 13 | $23 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Biloxi
- Dawn HansenBiloxi$9K
- Timothy SkeltonBiloxi$7K
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Indira VeerisettyRidgeland$25K
- James BridgesMadison$23K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
- Jeffrey DennisOxford$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.